Summary

MARKET OUTLOOK
Based on Triton’s report, the global multiplex assay market is deemed to witness growth at a CAGR of 8.56% during the forecasting years 2024-2032.
Factors such as the adoption of personalized medications, the high adoption of multiplex assays over traditional methods, and the increasing prevalence of chronic conditions drive the multiplex assay market. Conventional assay techniques are known for their time-consuming nature and their capacity to analyze only one assay per cycle. As a result, there has been a notable shift towards multiplex assays, primarily due to their ability to enhance efficiency, increase output volume, and reduce operational costs.
However, issues related to cross-reactivity and a lack of skilled professionals restrict the development of the multiplex assay market.
REGIONAL OUTLOOK
The global multiplex assay market covers the Middle East and Africa, North America, Asia-Pacific, Latin America, and Europe regions.
The Asia-Pacific is expected to emerge as the fastest-growing region over the forecast period. The regional market’s expansion is propelled by the growing demand for healthcare infrastructure, the rising number of hospitals in developing nations, and the evolving R&D sector. Additionally, the upsurge in healthcare reforms and technological innovations in the healthcare domain contribute significantly to the market’s growth.
COMPETITIVE OUTLOOK
The key companies in the multiplex assay market consist of Becton, Dickinson and Company, Abcam Limited, Bio-Rad Laboratories Inc, F. Hoffmann-la Roche Ltd, Bio-Techne Corporation, Merck Millipore, Agilent Technologies Inc, Qiagen NV, Illumina Inc, Seegene Inc, Siemens Healthineers AG, Olink Proteomics AB, Thermo Fisher Scientific Inc, and Randox Laboratories Ltd.
Siemens Healthineers AG serves as the parent company to various medical technology firms. It operates under the umbrella of Siemens AG. The company’s portfolio encompasses the production of medical, surgical, ophthalmic, and veterinary instruments and equipment, coupled with comprehensive imaging, diagnostics, advanced therapies, and services. Siemens holds a prominent position in the imaging systems market, having spearheaded innovations in computed tomography, MRI, molecular imaging, ultrasound, and imaging IT. Its operational footprint extends across the Americas, Europe, Africa, the Middle East, and Asia.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1. GLOBAL MULTIPLEX ASSAY MARKET- SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT ANALYSIS ON THE MULTIPLEX ASSAY MARKET
2.1.1. IMPACT OF COVID-19 ON THE MULTIPLEX ASSAY MARKET
2.2. PORTER’S FIVE FORCES MODEL
2.2.1. THREAT OF NEW ENTRANTS
2.2.2. THREAT OF SUBSTITUTE PRODUCTS
2.2.3. BARGAINING POWER OF BUYERS
2.2.4. BARGAINING POWER OF SUPPLIERS
2.2.5. COMPETITIVE RIVALRY
2.3. KEY BUYING IMPACT ANALYSIS
2.3.1. ANALYTE COVERAGE
2.3.2. SPEED
2.3.3. MULTIPLEXING CAPABILITY
2.3.4. EASE OF USE
2.3.5. AUTOMATION
2.4. MARKET ATTRACTIVENESS INDEX
2.5. KEY MARKET STRATEGIES
2.5.1. CONTRACTS AND PARTNERSHIPS
2.5.2. BUSINESS EXPANSIONS & DIVESTITURES
2.5.3. ACQUISITIONS & MERGERS
2.5.4. PRODUCT LAUNCHES & DEVELOPMENTS
2.6. MARKET DRIVERS
2.6.1. ADOPTION OF PERSONALIZED MEDICINES
2.6.2. HIGH ADOPTION OF MULTIPLEX ASSAYS OVER TRADITIONAL METHODS
2.6.3. INCREASING PREVALENCE OF CHRONIC DISEASES
2.7. MARKET CHALLENGES
2.7.1. ISSUES RELATED TO CROSS-REACTIVITY AND ASSAY INTERFERENCE
2.7.2. CHALLENGE IN ACHIEVING ADEQUATE ASSAY RANGE
2.7.3. DEARTH OF SKILLED PROFESSIONALS
2.8. MARKET OPPORTUNITIES
2.8.1. TECHNOLOGICAL ADVANCEMENTS IN ASSAY PLATFORMS
2.8.2. RAPID GROWTH OF COMPANION DIAGNOSTICS
2.8.3. GROWTH IN DRUG DISCOVERY INITIATIVES
2.9. ANALYST PERSPECTIVE
3. GLOBAL MULTIPLEX ASSAY MARKET - BY PRODUCT AND SERVICE
3.1. REAGENTS AND CONSUMABLES
3.2. INSTRUMENTS AND ACCESSORIES
3.3. SOFTWARE AND SERVICES
4. GLOBAL MULTIPLEX ASSAY MARKET - BY TYPE
4.1. PROTEIN-BASED MULTIPLEX ASSAY
4.2. NUCLEIC ACID-BASED MULTIPLEX ASSAY
4.3. OTHER MULTIPLEX ASSAYS
5. GLOBAL MULTIPLEX ASSAY MARKET - BY APPLICATION
5.1. RESEARCH AND DEVELOPMENT
5.2. CLINICAL DIAGNOSTICS
5.3. COMPANION DIAGNOSTICS
6. GLOBAL MULTIPLEX ASSAY MARKET - BY TECHNOLOGY
6.1. MULTIPLEX PROTEIN MICROARRAY
6.2. MULTIPLEX PCR
6.3. OTHER TECHNOLOGIES
7. GLOBAL MULTIPLEX ASSAY MARKET - BY INDUSTRY VERTICAL
7.1. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
7.2. RESEARCH INSTITUTES
7.3. CLINICAL LABORATORIES
7.4. HOSPITALS
8. GLOBAL MULTIPLEX ASSAY MARKET – BY REGIONAL OUTLOOK
8.1. NORTH AMERICA
8.1.1. MARKET BY PRODUCT AND SERVICE
8.1.2. MARKET BY TYPE
8.1.3. MARKET BY APPLICATION
8.1.4. MARKET BY TECHNOLOGY
8.1.5. MARKET BY INDUSTRY VERTICAL
8.1.6. COUNTRY ANALYSIS
8.1.6.1. UNITED STATES
8.1.6.1.1. UNITED STATES MULTIPLEX ASSAY MARKET FORECAST & PROSPECTS
8.1.6.2. CANADA
8.1.6.2.1. CANADA MULTIPLEX ASSAY MARKET FORECAST & PROSPECTS
8.2. EUROPE
8.2.1. MARKET BY PRODUCT AND SERVICE
8.2.2. MARKET BY TYPE
8.2.3. MARKET BY APPLICATION
8.2.4. MARKET BY TECHNOLOGY
8.2.5. MARKET BY INDUSTRY VERTICAL
8.2.6. COUNTRY ANALYSIS
8.2.6.1. GERMANY
8.2.6.1.1. GERMANY MULTIPLEX ASSAY MARKET FORECAST & PROSPECTS
8.2.6.2. UNITED KINGDOM
8.2.6.2.1. UNITED KINGDOM MULTIPLEX ASSAY MARKET FORECAST & PROSPECTS
8.2.6.3. FRANCE
8.2.6.3.1. FRANCE MULTIPLEX ASSAY MARKET FORECAST & PROSPECTS
8.2.6.4. ITALY
8.2.6.4.1. ITALY MARKET FORECAST & PROSPECTS
8.2.6.5. SPAIN
8.2.6.5.1. SPAIN MULTIPLEX ASSAY MARKET FORECAST & PROSPECTS
8.2.6.6. NETHERLANDS
8.2.6.6.1. NETHERLANDS MULTIPLEX ASSAY MARKET FORECAST & PROSPECTS
8.2.6.7. REST OF EUROPE
8.2.6.7.1. REST OF EUROPE MULTIPLEX ASSAY MARKET FORECAST & PROSPECTS
8.3. ASIA-PACIFIC
8.3.1. MARKET BY PRODUCT AND SERVICE
8.3.2. MARKET BY TYPE
8.3.3. MARKET BY APPLICATION
8.3.4. MARKET BY TECHNOLOGY
8.3.5. MARKET BY INDUSTRY VERTICAL
8.3.6. COUNTRY ANALYSIS
8.3.6.1. CHINA
8.3.6.1.1. CHINA MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.3.6.2. JAPAN
8.3.6.2.1. JAPAN MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.3.6.3. INDIA
8.3.6.3.1. INDIA MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.3.6.4. ASEAN COUNTRIES
8.3.6.4.1. ASEAN COUNTRIES MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.3.6.5. AUSTRALIA & NEW ZEALAND
8.3.6.5.1. AUSTRALIA & NEW ZEALAND MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.3.6.6. SOUTH KOREA
8.3.6.6.1. SOUTH KOREA MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.3.6.7. REST OF ASIA-PACIFIC
8.3.6.7.1. REST OF ASIA-PACIFIC MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.4. LATIN AMERICA
8.4.1. MARKET BY PRODUCT AND SERVICE
8.4.2. MARKET BY TYPE
8.4.3. MARKET BY APPLICATION
8.4.4. MARKET BY TECHNOLOGY
8.4.5. MARKET BY INDUSTRY VERTICAL
8.4.6. COUNTRY ANALYSIS
8.4.6.1. BRAZIL
8.4.6.1.1. BRAZIL MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.4.6.2. MEXICO
8.4.6.2.1. MEXICO MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.4.6.3. REST OF LATIN AMERICA
8.4.6.3.1. REST OF LATIN AMERICA MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.5. MIDDLE EAST AND AFRICA
8.5.1. MARKET BY PRODUCT AND SERVICE
8.5.2. MARKET BY TYPE
8.5.3. MARKET BY APPLICATION
8.5.4. MARKET BY TECHNOLOGY
8.5.5. MARKET BY INDUSTRY VERTICAL
8.5.6. COUNTRY ANALYSIS
8.5.6.1. UNITED ARAB EMIRATES
8.5.6.1.1. UNITED ARAB EMIRATES MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.5.6.2. SAUDI ARABIA
8.5.6.2.1. SAUDI ARABIA MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.5.6.3. TURKEY
8.5.6.3.1. TURKEY MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.5.6.4. SOUTH AFRICA
8.5.6.4.1. SOUTH AFRICA MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.5.6.5. REST OF MIDDLE EAST & AFRICA
8.5.6.5.1. REST OF MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
9. COMPETITIVE LANDSCAPE
9.1. ABCAM LIMITED
9.1.1. OVERVIEW
9.1.2. PRODUCT PORTFOLIO
9.2. AGILENT TECHNOLOGIES INC
9.2.1. OVERVIEW
9.2.2. PRODUCT PORTFOLIO
9.2.3. KEY STRENGTHS
9.2.4. KEY CHALLENGES
9.3. BECTON DICKINSON AND COMPANY (BD)
9.3.1. OVERVIEW
9.3.2. PRODUCT PORTFOLIO
9.3.3. KEY STRENGTHS
9.3.4. KEY CHALLENGES
9.4. BIO-RAD LABORATORIES INC
9.4.1. OVERVIEW
9.4.2. PRODUCT PORTFOLIO
9.4.3. KEY STRENGTHS
9.4.4. KEY CHALLENGES
9.5. BIO-TECHNE CORPORATION
9.5.1. OVERVIEW
9.5.2. PRODUCT PORTFOLIO
9.6. F. HOFFMANN-LA ROCHE LTD
9.6.1. OVERVIEW
9.6.2. PRODUCT PORTFOLIO
9.6.3. KEY STRENGTHS
9.6.4. KEY CHALLENGES
9.7. ILLUMINA INC
9.7.1. OVERVIEW
9.7.2. PRODUCT PORTFOLIO
9.7.3. KEY STRENGTHS
9.7.4. KEY CHALLENGES
9.8. MERCK MILLIPORE
9.8.1. OVERVIEW
9.8.2. PRODUCT PORTFOLIO
9.9. OLINK PROTEOMICS AB
9.9.1. OVERVIEW
9.9.2. PRODUCT PORTFOLIO
9.10. QIAGEN NV
9.10.1. OVERVIEW
9.10.2. PRODUCT PORTFOLIO
9.10.3. KEY STRENGTHS
9.10.4. KEY CHALLENGES
9.11. RANDOX LABORATORIES LTD
9.11.1. OVERVIEW
9.11.2. PRODUCT PORTFOLIO
9.12. SEEGENE INC
9.12.1. OVERVIEW
9.12.2. PRODUCT PORTFOLIO
9.13. SIEMENS HEALTHINEERS AG
9.13.1. OVERVIEW
9.13.2. PRODUCT PORTFOLIO
9.13.3. KEY STRENGTHS
9.13.4. KEY CHALLENGES
9.14. THERMO FISHER SCIENTIFIC INC
9.14.1. OVERVIEW
9.14.2. PRODUCT PORTFOLIO
9.14.3. KEY STRENGTHS
9.14.4. KEY CHALLENGES
10. RESEARCH METHODOLOGY & SCOPE
10.1. RESEARCH SCOPE & DELIVERABLES
10.2. SOURCES OF DATA
10.3. RESEARCH METHODOLOGY

LIST OF TABLES
TABLE 1: GLOBAL MULTIPLEX ASSAY MARKET, BY REGIONAL OUTLOOK, HISTORICAL YEARS, 2020-2023 (IN $ MILLION)
TABLE 2: GLOBAL MULTIPLEX ASSAY MARKET, BY REGIONAL OUTLOOK, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 3: CONTRACTS AND PARTNERSHIPS
TABLE 4: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
TABLE 5: ACQUISITIONS & MERGERS
TABLE 6: LIST OF NEW PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 7: GLOBAL MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2024-2032 (IN $ MILLION)
TABLE 8: GLOBAL MULTIPLEX ASSAY MARKET, BY TYPE, 2024-2032 (IN $ MILLION)
TABLE 9: GLOBAL MULTIPLEX ASSAY MARKET, BY APPLICATION, 2024-2032 (IN $ MILLION)
TABLE 10: GLOBAL MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2024-2032 (IN $ MILLION)
TABLE 11: GLOBAL MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)
TABLE 12: GLOBAL MULTIPLEX ASSAY MARKET, BY REGIONAL OUTLOOK, HISTORICAL YEARS, 2020-2023 (IN $ MILLION)
TABLE 13: GLOBAL MULTIPLEX ASSAY MARKET, BY REGIONAL OUTLOOK, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 14: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 15: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2024-2032 (IN $ MILLION)
TABLE 16: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TYPE, 2024-2032 (IN $ MILLION)
TABLE 17: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2024-2032 (IN $ MILLION)
TABLE 18: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2024-2032 (IN $ MILLION)
TABLE 19: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)
TABLE 20: EUROPE MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 21: EUROPE MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2024-2032 (IN $ MILLION)
TABLE 22: EUROPE MULTIPLEX ASSAY MARKET, BY TYPE, 2024-2032 (IN $ MILLION)
TABLE 23: EUROPE MULTIPLEX ASSAY MARKET, BY APPLICATION, 2024-2032 (IN $ MILLION)
TABLE 24: EUROPE MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2024-2032 (IN $ MILLION)
TABLE 25: EUROPE MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)
TABLE 26: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 27: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2024-2032 (IN $ MILLION)
TABLE 28: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY TYPE, 2024-2032 (IN $ MILLION)
TABLE 29: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY APPLICATION, 2024-2032 (IN $ MILLION)
TABLE 30: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2024-2032 (IN $ MILLION)
TABLE 31: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)
TABLE 32: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 33: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2024-2032 (IN $ MILLION)
TABLE 34: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY TYPE, 2024-2032 (IN $ MILLION)
TABLE 35: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2024-2032 (IN $ MILLION)
TABLE 36: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2024-2032 (IN $ MILLION)
TABLE 37: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)
TABLE 38: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 39: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2024-2032 (IN $ MILLION)
TABLE 40: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY TYPE, 2024-2032 (IN $ MILLION)
TABLE 41: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2024-2032 (IN $ MILLION)
TABLE 42: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2024-2032 (IN $ MILLION)
TABLE 43: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)
LIST OF FIGURES
FIGURE 1: GLOBAL MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2023 & 2032, (IN %)
FIGURE 2: GLOBAL MULTIPLEX ASSAY MARKET, BY REAGENTS AND CONSUMABLES, 2024-2032 (IN $ MILLION)
FIGURE 3: GLOBAL MULTIPLEX ASSAY MARKET, BY INSTRUMENTS AND ACCESSORIES, 2024-2032 (IN $ MILLION)
FIGURE 4: GLOBAL MULTIPLEX ASSAY MARKET, BY SOFTWARE AND SERVICES, 2024-2032 (IN $ MILLION)
FIGURE 5: GLOBAL MULTIPLEX ASSAY MARKET, BY TYPE, 2023 & 2032 (IN %)
FIGURE 6: GLOBAL MULTIPLEX ASSAY MARKET, BY PROTEIN-BASED MULTIPLEX ASSAY, 2024-2032 (IN $ MILLION)
FIGURE 7: GLOBAL MULTIPLEX ASSAY MARKET, BY NUCLEIC ACID-BASED MULTIPLEX ASSAY, 2024-2032 (IN $ MILLION)
FIGURE 8: GLOBAL MULTIPLEX ASSAY MARKET, BY OTHER MULTIPLEX ASSAYS, 2024-2032 (IN $ MILLION)
FIGURE 9: GLOBAL MULTIPLEX ASSAY MARKET, BY APPLICATION, 2023 & 2032, (IN %)
FIGURE 10: GLOBAL MULTIPLEX ASSAY MARKET, BY RESEARCH AND DEVELOPMENT, 2024-2032 (IN $ MILLION)
FIGURE 11: GLOBAL MULTIPLEX ASSAY MARKET, BY CLINICAL DIAGNOSTICS, 2024-2032 (IN $ MILLION)
FIGURE 12: GLOBAL MULTIPLEX ASSAY MARKET, BY COMPANION DIAGNOSTICS, 2024-2032 (IN $ MILLION)
FIGURE 13: GLOBAL MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2023 & 2032 (IN %)
FIGURE 14: GLOBAL MULTIPLEX ASSAY MARKET, BY MULTIPLEX PROTEIN MICROARRAY, 2024-2032 (IN $ MILLION)
FIGURE 15: GLOBAL MULTIPLEX ASSAY MARKET, BY MULTIPLEX PCR, 2024-2032 (IN $ MILLION)
FIGURE 16: GLOBAL MULTIPLEX ASSAY MARKET, BY OTHER TECHNOLOGIES, 2024-2032 (IN $ MILLION)
FIGURE 17: GLOBAL MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICAL, 2023 & 2032, (IN %)
FIGURE 18: GLOBAL MULTIPLEX ASSAY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2024-2032 (IN $ MILLION)
FIGURE 19: GLOBAL MULTIPLEX ASSAY MARKET, BY RESEARCH INSTITUTES, 2024-2032 (IN $ MILLION)
FIGURE 20: GLOBAL MULTIPLEX ASSAY MARKET, BY CLINICAL LABORATORIES, 2024-2032 (IN $ MILLION)
FIGURE 21: GLOBAL MULTIPLEX ASSAY MARKET, BY HOSPITALS, 2024-2032 (IN $ MILLION)
FIGURE 22: GLOBAL MULTIPLEX ASSAY MARKET, BY REGIONAL OUTLOOK, 2023 & 2032 (IN %)
FIGURE 23: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 24: UNITED STATES MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)
FIGURE 25: CANADA MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE 26: EUROPE MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 27: GERMANY MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE 28: UNITED KINGDOM MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE 29: FRANCE MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE 30: ITALY MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE 31: SPAIN MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE 32: NETHERLANDS MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE 33: REST OF EUROPE MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE 34: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 35: CHINA MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE 36: JAPAN MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE 37: INDIA MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE 38: ASEAN COUNTRIES MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE 39: AUSTRALIA & NEW ZEALAND MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE 40: SOUTH KOREA MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE 41: REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE 42: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 43: BRAZIL MULTIPLEX ASSAYS MARKET 2024-2032 (IN $ MILLION)
FIGURE 44: MEXICO MULTIPLEX ASSAYS MARKET 2024-2032 (IN $ MILLION)
FIGURE 45: REST OF LATIN AMERICA MULTIPLEX ASSAYS MARKET 2024-2032 (IN $ MILLION)
FIGURE 46: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 47: UNITED ARAB EMIRATES MULTIPLEX ASSAYS MARKET 2024-2032 (IN $ MILLION)
FIGURE 48: SAUDI ARABIA MULTIPLEX ASSAYS MARKET 2024-2032 (IN $ MILLION)
FIGURE 49: TURKEY MULTIPLEX ASSAYS MARKET 2024-2032 (IN $ MILLION)
FIGURE 50: SOUTH AFRICA MULTIPLEX ASSAYS MARKET 2024-2032 (IN $ MILLION)
FIGURE 51: REST OF MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET 2024-2032 (IN $ MILLION)